[1]
|
Al-Wahbi, A.M. (2006) The diabetic foot in the Arab world. Saudi Medical Journal, 27, 147-153.
|
[2]
|
Al Zahrani, H., Ghandourah, N. and Merdad, H. (1992) Limb amputations in Western Saudi Arabia. Asian Journal of Surgery, 15, 119-122.
|
[3]
|
Al-Tawfiq, J.A. and Johndrow, J.A. (2009) Presentation and outcome of diabetic foot ulcers in Saudi Arabian patients. Advances in Skin & Wound Care, 22, 119-121.
doi:10.1097/01.ASW.0000305450.33693.f8
|
[4]
|
Robbins, J.M., Strauss, G., Aron, D., Long, J., Kuba, J. and Kaplan, Y. (2008) Mortality rates and diabetic foot ulcers is it time to communicate mortality risk to patients with diabetic foot ulceration? Journal of the American Podiatric Medical Association, 98, 489-493.
|
[5]
|
Alzahrani, H.A. and Sehlo, M.G. (2011) The impact of religious connectedness on health-related quality of life in patients with diabetic foot ulcers. Journal of Religion and Health, 2011, 1-11.
|
[6]
|
Kalish, J. and Hamdan, A. (2010) Management of diabetic foot problems. Journal of Vascular Surgery, 51, 476-486. doi:10.1016/j.jvs.2009.08.043
|
[7]
|
Dinh, T.L. and Veves, A. (2006) The efficacy of apligraf in the treatment of diabetic foot ulcers. Plastic and Reconstructive Surgery, 117, 152S-157S.
doi:10.1097/01.prs.0000222534.79915.d3
|
[8]
|
Curran, M.P. and Plosker, G.L. (2002) Bilayered bioengineered skin substitute (Apligraf): A review of its use in the treatment of venous leg ulcers and diabetic foot ulcers. BioDrugs, 16, 439-455.
doi:10.2165/00063030-200216060-00005
|
[9]
|
Edmonds, M. (2009) Apligraf in the treatment of neuropathic diabetic foot ulcers. The International Journal of Lower Extremity Wounds, 8, 11-18.
doi:10.1177/1534734609331597
|
[10]
|
Steinberg, J.S., Edmonds, M., Hurley, D.P. and King, W.N. (2010) Confirmatory data from EU study supports apligraf for the treatment of neuropathic diabetic foot ulcers. Journal of the American Podiatric Medical Association, 100, 73-77.
|
[11]
|
Felder III, J.M., Goyal, S.S. and Attinger, C.E. (2012) A systematic review of skin substitutes for foot ulcers. Plastic and Reconstructive Surgery, 130, 145-164.
doi:10.1097/PRS.0b013e318254b1ea
|
[12]
|
Langer, A. and Rogowski, W. (2009) Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers. BMC Health Services Research, 9, 115.
doi:10.1186/1472-6963-9-115
|
[13]
|
Apelqvist, J., Bakker, K., Van Houtum, W. and Schaper, N. (2008) Practical guidelines on the management and prevention of the diabetic foot. Diabetes/Metabolism Research and Reviews, 24, S181-S187.
doi:10.1002/dmrr.848
|